Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2015
Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonismStanley B Prusiner, Amanda L Woerman, Daniel A Mordes, et al.
Journal of Medicinal Chemistry|January 11, 2002
4-(Phenylsulfonyl)piperidines: novel, selective, and bioavailable 5-HT(2A) receptor antagonistsStephen R Fletcher, Frank Burkamp, Peter Blurton, et al.
The European Journal of Neuroscience|July 28, 2019
The priming effect of food persists following blockade of dopamine receptorsCzarina Evangelista, Arne Hantson, Waqqas M Shams, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2015
Propagation of prions causing synucleinopathies in cultured cellsAmanda L Woerman, Jan Stöhr, Atsushi Aoyagi, et al.
Frontiers in Neurology|February 6, 2019
Alzheimer's "Prevention" vs. "Risk Reduction": Transcending Semantics for Clinical PracticeJohn F Hodes, Carlee I Oakley, James H O'Keefe, et al.
JCI Insight|March 13, 2020
Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutationEmmanuel Martin, Norbert Minet, Anne-Claire Boschat, et al.
The Journal of Allergy and Clinical Immunology|June 20, 2014
Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriersClaire Aguilar, Christelle Lenoir, Nathalie Lambert, et al.
Blood|September 28, 2019
The whole-genome landscape of Burkitt lymphoma subtypesRazvan I Panea, Cassandra L Love, Jennifer R Shingleton, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 26, 2025
Clinical and Molecular Characteristics of X-Linked Agammaglobulinemia Patients 55 Years or OlderAaron T Chin, Hans D Ochs, Roger Kobayashi, et al.
Pageof 21